Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II.

[1]  J. Whitton,et al.  Precursor Frequency, Nonlinear Proliferation, and Functional Maturation of Virus-Specific CD4+ T Cells1 , 2006, The Journal of Immunology.

[2]  Emil R Unanue,et al.  The wide diversity and complexity of peptides bound to class II MHC molecules. , 2006, Current opinion in immunology.

[3]  A. Theofilopoulos,et al.  Lack of Intrinsic CTLA-4 Expression Has Minimal Effect on Regulation of Antiviral T-Cell Immunity , 2006, Journal of Virology.

[4]  C. Boog,et al.  Mass Tag-Assisted Identification of Naturally Processed HLA Class II-Presented Meningococcal Peptides Recognized by CD4+ T Lymphocytes , 2005, The Journal of Immunology.

[5]  Yasmine Belkaid,et al.  Natural regulatory T cells in infectious disease , 2005, Nature Immunology.

[6]  V. Appay.  The physiological role of cytotoxic CD4+ T‐cells: the holy grail? , 2004, Clinical and experimental immunology.

[7]  E. Pearce,et al.  Functional Characterization of MHC Class II-Restricted CD8+CD4− and CD8−CD4− T Cell Responses to Infection in CD4−/− Mice1 , 2004, The Journal of Immunology.

[8]  M. Bevan.  Helping the CD8+ T-cell response , 2004, Nature Reviews Immunology.

[9]  J. Sprent,et al.  IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Oxenius,et al.  Immediate Cytotoxicity But Not Degranulation Distinguishes Effector and Memory Subsets of CD8+ T Cells , 2004, The Journal of experimental medicine.

[11]  P. Greenberg,et al.  Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. , 2004, Immunity.

[12]  A. Tyznik,et al.  The CD8 Population in CD4-deficient Mice Is Heavily Contaminated with MHC Class II–restricted T Cells , 2004, The Journal of experimental medicine.

[13]  S. Kaufmann,et al.  Mini‐review: Regulatory T cells and infection: suppression revisited , 2004, European journal of immunology.

[14]  J. Sprent,et al.  T cell memory. , 2003, Annual review of immunology.

[15]  Alessandro Sette,et al.  Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. , 2003, Virology.

[16]  R. Ahmed,et al.  Similarities and differences in CD4+ and CD8+ effector and memory T cell generation , 2003, Nature Immunology.

[17]  S. Naylor,et al.  Naturally processed measles virus peptide eluted from class II HLA-DRB1*03 recognized by T lymphocytes from human blood. , 2003, Virology.

[18]  Ian A Wilson,et al.  Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif. , 2003, Journal of molecular biology.

[19]  Dirk Homann,et al.  Detection of Low-Avidity CD4+ T Cells Using Recombinant Artificial APC: Following the Antiovalbumin Immune Response1 , 2003, The Journal of Immunology.

[20]  D. Burton.  Antibodies, viruses and vaccines , 2002, Nature Reviews Immunology.

[21]  R. Zinkernagel,et al.  On differences between immunity and immunological memory. , 2002, Current opinion in immunology.

[22]  V. Apostolopoulos,et al.  Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: a novel use of alternative anchors. , 2002, Journal of molecular biology.

[23]  Eric S. Rosenberg,et al.  CD4+ T helper cells and the role they play in viral control , 2002, Journal of Molecular Medicine.

[24]  M. V. von Herrath,et al.  CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. , 2002, Immunity.

[25]  H. Grey,et al.  How H13 Histocompatibility Peptides Differing by a Single Methyl Group and Lacking Conventional MHC Binding Anchor Motifs Determine Self-Nonself Discrimination1 , 2002, The Journal of Immunology.

[26]  Dirk Homann,et al.  Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory , 2001, Nature Medicine.

[27]  A. Rudensky,et al.  In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses , 2001, European journal of immunology.

[28]  M. Davis,et al.  Thirty-six views of T-cell recognition. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[29]  S. Varga,et al.  High Frequency of Virus-Specific Interleukin-2-Producing CD4+ T Cells and Th1 Dominance during Lymphocytic Choriomeningitis Virus Infection , 2000, Journal of Virology.

[30]  K. Garcia,et al.  A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. , 2000, Science.

[31]  M. Oldstone,et al.  Defining parameters for successful immunocytotherapy of persistent viral infection. , 2000, Virology.

[32]  C. Kamperschroer,et al.  Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection. , 1999, Cellular immunology.

[33]  M. V. von Herrath,et al.  Evidence for an Underlying CD4 Helper and CD8 T-Cell Defect in B-Cell-Deficient Mice: Failure To Clear Persistent Virus Infection after Adoptive Immunotherapy with Virus-Specific Memory Cells from μMT/μMT Mice , 1998, Journal of Virology.

[34]  R. Ahmed,et al.  Long-Term CD4 Th1 and Th2 Memory following Acute Lymphocytic Choriomeningitis Virus Infection , 1998, Journal of Virology.

[35]  S. Varga,et al.  Detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus. , 1998, Journal of Immunology.

[36]  S. Varga,et al.  Stability of virus-specific CD4+ T cell frequencies from acute infection into long term memory. , 1998, Journal of immunology.

[37]  P. A. Peterson,et al.  Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.

[38]  C Oseroff,et al.  Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. , 1998, Virology.

[39]  L R Pease,et al.  Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Oldstone,et al.  The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules. , 1997, Virology.

[41]  K. Garcia,et al.  Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules , 1996, The Journal of experimental medicine.

[42]  S. Tonegawa,et al.  Presentation of endogenous viral proteins in association with major histocompatibility complex class II: On the role of intracellular compartmentalization, invariant chain and the TAP transporter system , 1995, European journal of immunology.

[43]  M. Oldstone,et al.  Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes , 1995, Journal of virology.

[44]  R. Seder.  Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, The Journal of allergy and clinical immunology.

[45]  P. A. Peterson,et al.  Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.

[46]  M R Jackson,et al.  In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. , 1992, The Journal of biological chemistry.

[47]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[48]  J. Whitton,et al.  Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. , 1990, Virology.

[49]  R. Zinkernagel,et al.  Major histocompatibility complex – dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease , 1989, European journal of immunology.

[50]  J. Whitton,et al.  Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes , 1988, The Journal of experimental medicine.

[51]  M. Oldstone,et al.  Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus and in vitro properties , 1985, Journal of virology.

[52]  M. Oldstone,et al.  Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo , 1984, Journal of virology.

[53]  J. Panus,et al.  Helper T-cell-regulated B-cell immunity. , 2003, Microbes and infection.

[54]  A. Khoruts,et al.  In vivo activation of antigen-specific CD4 T cells. , 2001, Annual review of immunology.

[55]  H. McFarland,et al.  The Immune Response to Viruses , 1989 .